Inovio Pharmaceuticals
INO
$10.57
Share price
4.40%
Change (1 day)
1,272.73%
Change (1 year)
Categories
Inovio Pharmaceuticals (INO) - Cash on Hand
Cash on Hand as of December 2023 : $0.14 B
According to Inovio Pharmaceuticals's latest financial reports the company has $0.14 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Inovio Pharmaceuticals - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.14 B | -42.57% |
| 2022-12-31 | $0.25 B | -36.96% |
| 2021-12-31 | $0.40 B | -2.51% |
| 2020-12-31 | $0.41 B | 359.76% |
| 2019-12-31 | $89.53 M | 10.22% |
| 2018-12-31 | $81.23 M | -36.25% |
| 2017-12-31 | $0.12 B | 21.63% |
| 2016-12-31 | $0.10 B | -35.72% |
| 2015-12-31 | $0.16 B | 74.1% |
| 2014-12-31 | $93.61 M | 77.9% |
| 2013-12-31 | $52.62 M | 284.69% |
| 2012-12-31 | $13.68 M | -54.72% |
| 2011-12-31 | $30.21 M | 38.31% |
| 2010-12-31 | $21.84 M | -50.17% |
| 2009-12-31 | $43.83 M | 210.58% |
| 2008-12-31 | $14.11 M | -48.2% |
| 2007-12-31 | $27.25 M | 18.37% |
| 2006-12-31 | $23.02 M | 34.11% |
| 2005-12-31 | $17.16 M | -4.04% |
| 2004-12-31 | $17.88 M | 32.91% |
| 2003-12-31 | $13.46 M | 1437.56% |
| 2002-12-31 | $0.87 M | -51.72% |
| 2001-12-31 | $1.81 M | |
| 2001-03-31 | $6.52 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 15,679.73% | 🇺🇸 USA |
 Novartis NVS | $9.69 B | 6,571.99% | 🇨🇭 Switzerland |
 Pfizer PFE | $12.69 B | 8,634.02% | 🇺🇸 USA |
 Gilead Sciences GILD | $7.26 B | 4,899.52% | 🇺🇸 USA |
 Merck MRK | $7.09 B | 4,781.83% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.35 B | 4,273.77% | 🇬🇧 UK |
 Cleveland BioLabs
CBLI | N/A | N/A | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | $0.22 B | 51.61% | 🇺🇸 USA |